ABVC BioPharma, Inc. Financial Ratios — ABVC Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-318.47	-84.73	-0.05	-6.05	-1,866.03	-277.74	-157.2	-299.41	-103.69	-105.65	-101.47	-141.11	-89.7	-63.99	-55.3
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	- -	84.49	- -	- -	- -	- -	97.13	96.13	98.57	70.47	-98.15	99.85	- -
EBITDA Margin (%)	-19,425.92	-1,969.95	- -	-960.74	- -	- -	- -	- -	-485.05	-1,753.18	-3,185.26	-1,556.08	-4,189.69	-883.91	- -
Operating Margin (%)	-20,004.31	-2,276.35	- -	-960.74	- -	- -	- -	- -	-492.9	-1,760.87	-3,188.64	-1,558.54	-4,439.24	-923.34	- -
Incremental Operating Margin (%)	- -	- -	-2,275.45	- -	326,339.7	- -	- -	- -	- -	- -	- -	- -	- -	- -	480
Pretax Margin (%)	-17,534.86	-2,906.79	- -	-960.74	- -	- -	- -	- -	-571.49	-2,238.7	-3,150.91	-1,599.8	-5,264.61	-1,053.71	- -
Profit Margin (%)	-18,718.57	-2,906.79	- -	-960.74	- -	- -	- -	- -	-518.98	-2,026.97	-3,608.47	-1,693.5	-5,109.26	-962.12	- -
Net Income to Common Margin (%)	-26,941.6	-3,035.78	- -	-960.74	- -	- -	- -	- -	-518.98	-2,026.97	-3,608.47	-1,693.5	-5,109.26	-962.12	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	30.52	4.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1	1	- -	- -	- -	- -	- -	1	5	6	3	3	3	2	3
ST Debt	1	1	- -	- -	- -	- -	- -	1	4	2	2	2	2	2	2
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	1	1	- -	- -	2
Total Debt/EBITDA	-1.01	-7.42	-100	-0.22	- -	- -	- -	-0.57	-1.35	-0.77	-0.27	-0.2	-0.41	-0.54	-0.52
Net Debt/EBITDA	-0.99	-7.42	-100	30.6	0.02	-0.98	0.02	-0.55	-1.14	-0.05	0.37	-0.12	-0.27	-0.34	-0.13
Total Debt/EBIT	-0.98	-6.42	-100	-0.22	- -	- -	- -	-0.57	-1.32	-0.76	-0.27	-0.2	-0.38	-0.52	-0.49
Net Debt/EBIT	-0.96	-6.42	-100	30.6	0.02	-0.98	0.02	-0.55	-1.13	-0.05	0.37	-0.12	-0.26	-0.33	-0.12
EBITDA to Interest Expense	-12.66	-3.12	- -	- -	-1,081.35	-53.31	-40	-8.94	-7.06	-20.91	-49.88	-51.33	-4.86	-5.45	-15.98
EBITDA-CapEx/Interest Expense	-12.88	-3.12	- -	- -	-1,081.35	-53.31	-40	-8.94	-7.06	-20.91	-49.96	-51.74	-4.88	-5.45	-15.98
EBIT to Interest Expense	-13.03	-3.61	- -	- -	-1,081.35	-53.31	-40	-8.94	-7.18	-21	-49.93	-51.42	-5.15	-5.7	-17.2
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -
Common Equity/Total Assets	-10,009.42	-13,146.44	-35.52	-14.9	-6,265.83	-551.09	-588.76	-20,425.22	-228.52	-220.72	-280.71	-573.11	-822.65	-914.28	-364.79
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	153.3	12.68	24.47	32.51	32.71	12.04
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-1.33	-2.1	-20.5	-3.19	-1.53	-0.66	-0.35	-2.25
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	259.68	3.4	35.16	8.21	8.27	5.23	3.14	7.6
Total Debt/Equity (%)	-67.87	-60.55	22.32	1.11	- -	- -	- -	-13.91	-3,668.9	243.53	35.08	94.4	207.03	335.75	26.12
Total Debt/Capital (%)	-3.83	-3.88	-43.15	-4.92	- -	- -	- -	-4.24	-40.79	-32.56	-8.81	-5.91	-4.2	-3.63	-4.88
Total Debt/Total Assets (%)	369.06	490.8	10.71	0.7	- -	- -	- -	830.97	66.1	55.86	22.72	31.89	33.34	32.24	16.49
Net Debt to Equity	-67.06	-60.52	22.32	-155.97	2.72	-280.54	5.31	-13.22	-3,120.82	16.42	-47.22	55.88	137.67	212.98	6.57
Net Debt/Capital (%)	-3.78	-3.88	-43.15	86.87	1.54	-25.4	0.6	-4.02	-34.26	-1.81	10.18	-3.49	-2.79	-2.29	-1.21
EBITDA	-1	- -	- -	- -	-11	-4	-4	-1	-3	-8	-11	-15	-6	-5	-7
EBITDA-CapEx	-1	- -	- -	- -	-11	-4	-4	-1	-3	-8	-11	-15	-6	-5	-7
Operating Income (Loss)	-1	- -	- -	- -	-11	-4	-4	-1	-3	-9	-11	-15	-7	-5	-7

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.01	- -	- -	2.7	0.03	0.05	0.02	0.01	0.02	0.88	1.61	0.03	0.02	0.05	0.12
Current Ratio	0.02	- -	0.02	2.71	0.03	0.66	0.6	0.02	0.13	1.27	2.07	0.54	0.27	0.33	0.41
Quick Ratio	0.01	- -	- -	2.7	0.03	0.66	0.6	0.01	0.12	1.09	1.72	0.28	0.15	0.22	0.24
CFO/Avg Current Liab	-0.48	-0.04	0.07	0.02	-1	-0.3	-0.35	-0.13	-0.51	-0.78	-1.78	-1.6	-0.72	-0.29	-0.47
Common Equity/Total Assets	-10,009.42	-13,146.44	-35.52	-14.9	-6,265.83	-551.09	-588.76	-20,425.22	-228.52	-220.72	-280.71	-573.11	-822.65	-914.28	-364.79
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	153.3	12.68	24.47	32.51	32.71	12.04
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-1.33	-2.1	-20.5	-3.19	-1.53	-0.66	-0.35	-2.25
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	259.68	3.4	35.16	8.21	8.27	5.23	3.14	7.6
Total Debt/Equity (%)	-67.87	-60.55	22.32	1.11	- -	- -	- -	-13.91	-3,668.9	243.53	35.08	94.4	207.03	335.75	26.12
Total Debt/Capital (%)	-3.83	-3.88	-43.15	-4.92	- -	- -	- -	-4.24	-40.79	-32.56	-8.81	-5.91	-4.2	-3.63	-4.88
Total Debt/Total Assets (%)	369.06	490.8	10.71	0.7	- -	- -	- -	830.97	66.1	55.86	22.72	31.89	33.34	32.24	16.49
CFO/Total Liabilities	-47.02	-1.79	3.43	0.91	-53	-38.54	-33.76	-10.78	-44.44	-51.02	-157.38	-116.63	-64.11	-26.54	-38.46
CFO/CapEx	-46.82	- -	- -	- -	- -	- -	- -	- -	- -	- -	-434.08	-61.81	-197.48	- -	- -
Altman's Z-Score	-509.37	-1,108.19	-79.85	203.52	-301.7	48.3	-5.94	-361.13	0.73	1.41	4.26	-11.58	-14.59	-14.88	-6.44

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	12.58	- -	- -	- -	- -	- -	- -	8.58	2.99	1.62	5.12	3.05	666.13	- -
Days Sales Outstanding	- -	29.01	- -	- -	- -	- -	- -	- -	42.54	122.14	225.9	71.33	119.55	0.55	- -
Inventory Turnover	- -	- -	- -	0.97	0.23	- -	- -	- -	- -	- -	0.39	22.05	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	374.46	1,562.66	- -	- -	- -	- -	- -	932.06	16.55	- -	- -	- -
Accounts Payable Turnover	- -	- -	0.01	- -	-0.03	- -	- -	- -	1.68	0.8	2.7	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	37,868.18	- -	-13,853.41	- -	- -	- -	217.46	458.68	135.4	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-174.93	-336.54	1,022.56	87.88	119.55	0.55	- -
Inventory to Cash Days	- -	- -	- -	-374.46	- -	- -	- -	- -	42.54	122.14	-706.16	54.77	119.55	0.55	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	1	1	1	125	388	425	61	428	76	101	85	20	5	7	- -
- Cash & Cash Equivalents	- -	- -	- -	1	- -	- -	- -	- -	- -	4	6	- -	- -	- -	1
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	- -	- -	- -	-1	2
+ Total Debt	1	1	- -	- -	- -	- -	- -	1	5	6	3	3	3	2	3
Enterprise Value	2	2	1	124	388	425	61	429	81	102	82	23	7	9	5
Total Capital	-29	-29	- -	- -	-11	-15	-16	-19	-11	-20	-35	-52	-62	-67	-71
Total Debt/Capital (%)	-3.83	-3.88	-43.15	-4.92	- -	- -	- -	-4.24	-40.79	-32.56	-8.81	-5.91	-4.2	-3.63	-4.88
Total Debt / EV	0.51	0.57	0.01	- -	- -	- -	- -	- -	0.06	0.06	0.04	0.13	0.36	0.29	0.71
EV/Sales	383.53	258.02	- -	36,927.03	- -	- -	- -	- -	115.33	211.12	230.84	23.53	47.13	16.69	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	177.41	565.5	36,927.03	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	177.41	565.5	36,927.03	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	1	1	1	125	388	425	61	428	76	101	85	20	5	7	- -
Diluted Enterprise Value	2	2	1	124	388	425	61	429	81	102	82	23	7	9	5
EV per Share	11,534.13	10,574.85	3,476.34	1,421.8	359.84	359.83	359.45	360.64	46.25	51.73	32.78	7.21	1.66	0.73	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	1	- -	1	- -
TTM EBITDA	-1	- -	- -	- -	-11	-4	-4	-1	-3	-8	-11	-15	-6	-5	-7
TTM Operating Income	-1	- -	- -	- -	-11	-4	-4	-1	-3	-9	-11	-15	-7	-5	-7
TTM Cash Flow to Firm	-1	- -	- -	- -	-3	-2	-1	- -	-3	-4	-7	-7	-3	-1	-3
TTM Free Cash Flow to Firm	-1	- -	- -	- -	-3	-2	-1	- -	-3	-4	-7	-7	-3	-1	-3

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-1.22	-23.07	559.51	37,221.03	-111.65	-266.03	-41.37	-678.79	-24.4	-22.03	-11.2	-2.72	-1.21	-3.81	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	2	1	124	388	425	61	429	81	102	82	23	7	9	5
Low Price	2,866.24	1,433.12	286.62	0.34	180	360	360	270	12.5	10.5	19.5	5	0.67	0.4	0.4
EV/Sales	383.53	258.02	- -	36,927.03	- -	- -	- -	- -	115.33	211.12	230.84	23.53	47.13	16.69	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-2.71	-4.56	-9,499.38	-4,464.63	-84.61	-104.45	-14.48	-97.02	-74.15	-7.06	-7.96	-3	-2.41	-2.13	- -
Price/Earnings High	-7.78	-32.25	-15,559.59	-15,496.75	-140.3	-104.45	-14.48	-104.3	-181.63	-11.07	-22.81	-7.6	-10.41	-5.83	- -
Price/Earnings Low	-0.35	-1.15	-777.97	-0.93	-17.62	-104.45	-14.48	-78.23	-6.01	-2.11	-3.81	-0.96	-0.38	-0.96	- -
Price/Book Value	-0.04	-0.03	-28.14	-837.5	-34.91	-28.01	-3.95	-21.75	-4.83	-3.92	-2.21	-0.36	-0.08	-0.1	- -
Price/Book Value Average	-0.14	-0.04	-28.63	-965.14	-83.82	-28.01	-3.95	-20.24	-17.06	-2.7	-2.66	-0.9	-0.29	-0.15	- -
Price/Book Value High	-0.4	-0.25	-46.9	-3,350.01	-138.98	-28.01	-3.95	-21.75	-41.78	-4.23	-7.62	-2.27	-1.27	-0.41	- -
Price/Book Value Low	-0.02	-0.01	-2.34	-0.2	-17.46	-28.01	-3.95	-16.32	-1.38	-0.81	-1.27	-0.29	-0.05	-0.07	- -
Price/Tangible Book Value	-0.59	-0.42	-19.66	219.89	-60.82	-305.3	-34.97	-74.4	-612.65	37.77	9.57	6.12	4.01	9.51	- -
Price/Tangible Book Value Average	-2.26	-0.52	-20.01	253.4	-146.01	-305.3	-34.97	-69.21	-2,163.59	25.95	11.52	15.23	14.97	14.44	- -
Price/Tangible Book Value High	-6.47	-3.68	-32.77	879.54	-242.11	-305.3	-34.97	-74.4	-5,299.32	40.73	33.02	38.55	64.68	39.51	- -
Price/Tangible Book Value Low	-0.29	-0.13	-1.64	0.05	-30.41	-305.3	-34.97	-55.8	-175.24	7.78	5.51	4.89	2.33	6.53	- -
Price/Sales	190.61	111.9	- -	37,221.03	- -	- -	- -	- -	108.97	208.16	238.71	20.41	32.99	13.52	- -
Price/Sales Average	731.4	138.36	- -	42,893.67	- -	- -	- -	- -	384.85	143.01	287.28	50.83	123.11	20.51	- -
Price/Sales High	2,096.76	979.09	- -	148,884.11	- -	- -	- -	- -	942.61	224.48	823.15	128.65	531.89	56.13	- -
Price/Sales Low	95.31	34.97	- -	8.93	- -	- -	- -	- -	31.17	42.86	137.31	16.33	19.17	9.28	- -
Price/Cash Flow	-1.19	-23.07	559.51	37,221.03	-111.65	-266.03	-41.37	-678.79	-24.4	-22.03	-11.18	-2.67	-1.2	-3.81	- -
Price/Cash Flow Average	-4.57	-28.53	569.31	42,893.67	-268.06	-266.03	-41.37	-631.43	-86.15	-15.14	-13.45	-6.66	-4.48	-5.78	- -
Price/Cash Flow High	-13.09	-201.87	932.51	148,884.11	-444.48	-266.03	-41.37	-678.79	-211.02	-23.76	-38.55	-16.86	-19.36	-15.81	- -
Price/Cash Flow Low	-0.6	-7.21	46.62	8.93	-55.83	-266.03	-41.37	-509.09	-6.98	-4.54	-6.43	-2.14	-0.7	-2.61	- -
Price/Free Cash Flow Average	-4.67	-28.53	569.31	42,893.67	-268.06	-266.03	-41.37	-631.43	-86.15	-15.14	-13.48	-6.77	-4.5	-5.78	- -
Price/Free Cash Flow High	-13.38	-201.87	932.51	148,884.11	-444.48	-266.03	-41.37	-678.79	-211.02	-23.76	-38.64	-17.14	-19.46	-15.81	- -
Price/Free Cash Flow Low	-0.61	-7.21	46.62	8.93	-55.83	-266.03	-41.37	-509.09	-6.98	-4.54	-6.44	-2.18	-0.7	-2.61	- -
EV/Sales Average	924.31	284.49	- -	42,599.68	- -	- -	- -	- -	391.2	145.98	279.72	54.03	137.77	23.81	- -
EV/Sales High	2,289.68	1,125.22	- -	148,590.11	- -	- -	- -	- -	948.96	227.45	815.59	131.85	546.55	59.42	- -
EV/Sales Low	288.22	181.09	- -	- -	- -	- -	- -	- -	37.53	45.82	129.75	19.53	33.83	12.58	- -
EV/EBITDA Average	-4.76	-14.44	-9,599.39	-4,434.03	-84.68	-106.37	-14.82	-286.08	-80.65	-8.33	-8.78	-3.47	-3.29	-2.69	-0.75
EV/EBITDA High	-11.79	-57.12	-15,659.6	-15,466.15	-140.42	-106.37	-14.82	-307.5	-195.64	-12.97	-25.61	-8.47	-13.05	-6.72	-0.75
EV/EBITDA Low	-1.48	-9.19	-877.98	29.67	-17.62	-106.37	-14.82	-230.76	-7.74	-2.61	-4.07	-1.26	-0.81	-1.42	-0.75
EV/EBIT Average	-4.62	-12.5	-9,599.39	-4,434.03	-84.68	-106.37	-14.82	-286.08	-79.37	-8.29	-8.77	-3.47	-3.1	-2.58	-0.7
EV/EBIT High	-11.45	-49.43	-15,659.6	-15,466.15	-140.42	-106.37	-14.82	-307.5	-192.53	-12.92	-25.58	-8.46	-12.31	-6.44	-0.7
EV/EBIT Low	-1.44	-7.96	-877.98	29.67	-17.62	-106.37	-14.82	-230.76	-7.61	-2.6	-4.07	-1.25	-0.76	-1.36	-0.7
Last Price	5,732.48	4,585.99	3,439.49	1,433.12	360	360	360	360	43.7	51	33.9	6.25	1.16	0.59	2.13
High Price	63,057.32	40,127.39	5,732.48	5,732.48	1,433.12	360	360	360	378	55	116.9	39.4	18.7	2.45	5.48
Enterprise Value Average	5	2	1	143	931	425	61	399	275	71	100	52	21	12	5
Enterprise Value High	13	9	1	499	1,544	425	61	429	666	110	290	128	83	30	5
Enterprise Value Low	2	1	- -	-1	194	425	61	322	26	22	46	19	5	6	5

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	1	1	1	1	1	2	2	3	3	8	13	24
Diluted Weighted Avg Shares	- -	- -	- -	- -	1	1	- -	1	2	2	3	3	4	12	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	1	1	- -	1	2	2	3	3	4	12	- -
Revenue per Share	30.07	40.98	- -	0.04	- -	- -	- -	- -	0.4	0.25	0.14	0.31	0.04	0.04	- -
EBITDA per Share	-5,842.09	-807.37	-0.37	-0.37	-10.2	-3.38	-24.25	-1.17	-1.95	-4.3	-4.52	-4.77	-1.47	-0.39	- -
Operating Income per Share	-6,016.03	-932.94	-0.37	-0.37	-10.2	-3.38	-24.25	-1.17	-1.98	-4.31	-4.53	-4.77	-1.56	-0.4	- -
Basic EPS, GAAP	-8,102.33	-1,244.19	-0.37	-0.37	-10.21	-3.45	-24.86	-3.45	-2.08	-4.97	-5.12	-5.19	-1.8	-0.42	- -
Basic EPS from Cont Ops	-5,629.36	-1,191.33	-0.37	-0.37	-10.21	-3.45	-24.86	-3.45	-2.25	-5.37	-4.8	-5.15	-1.91	-0.45	- -
Diluted EPS, GAAP	-8,102.33	-1,244.19	-0.37	-0.37	-10.21	-3.45	-24.86	-3.45	-2.08	-4.97	-5.12	-5.19	-1.8	-0.42	- -
Diluted EPS from Cont Ops	-5,629.36	-1,191.33	-0.37	-0.37	-10.21	-3.45	-24.86	-3.45	-2.25	-5.37	-4.8	-5.15	-1.91	-0.45	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-4,816.44	-198.78	6.15	0.04	-3.22	-1.35	-8.7	-0.53	-1.79	-2.31	-3.03	-2.34	-0.97	-0.15	- -
Free Cash Flow per Basic Share	-4,919.32	-198.78	6.15	0.04	-3.22	-1.35	-8.7	-0.53	-1.79	-2.31	-3.04	-2.37	-0.97	-0.15	- -
Cash & Equivalents per Share	70.45	3.25	- -	11.4	0.16	0.17	0.55	0.03	0.08	2.17	2.37	0.05	0.03	0.03	- -
Book Value per Share	-159,259.31	-160,503.5	-122.23	-1.71	-10.31	-12.85	-91.19	-16.55	-9.05	-12.99	-15.35	-17.34	-14.77	-5.91	- -
Tangible Book Value per Share	-9,741.94	-10,910.73	-174.93	6.52	-5.92	-1.18	-10.29	-4.84	-0.07	1.35	3.54	1.02	0.29	0.06	- -

ABVC BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)